FDA Approval Activities for this Drug
Moexipril Hydrochloride Tablets, 7.5 & 15 mg, Teva ANDA 76-204 Uniretic (moexipril hydrochloride/hydrochlorothiazide) Tablets, 7.5/12.5 and 15/25 mg Schwarz Pharma, NDA 20-729/S-010 Univasc and Uniretic (moexipril hydrochloride & hydrochlorothiazide) Tablets, Schwarz Pharma, NDA 20-312/S24 & 20-729/S12 10/29/03
Univasc (moexipril hydrochloride) Tablets Schwarz Pharma, NDA 20-312/S-016 Univasc and Uniretic (moexipril hydrochloride & hydrochlorothiazide) Tablets, Schwarz Pharma, HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE Tablet; 12.5MG;15MG UNIRETIC SCHWARZ 020729 HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE Tablet; 12.5MG;7.5MG UNIRETIC SCHWARZ 020729 HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE Tablet; 25MG;15MG UNIRETIC SCHWARZ 020312 MOEXIPRIL HYDROCHLORIDE Tablet; 15MG UNIVASC SCHWARZ 020312 MOEXIPRIL HYDROCHLORIDE Tablet; 7.5MG UNIVASC SCHWARZ 076204 MOEXIPRIL HYDROCHLORIDE Tablet; 15MG MOEXIPRIL HCL Teva
076204 MOEXIPRIL HYDROCHLORIDE Tablet; 7.5MG MOEXIPRIL HCL Teva | Moexipril Hydrochloride Tablets, Paddock Labs, Approval | Moexipril Hydrochloride and Hydrochlorothiazide Tablets, Teva Pharma, Approval | Moexipril Hydrochloride Tablets, Apotex Corp., Approval | Moexipril Hydrochloride and Hydrochlorothiazide Tablets, Paddock Laboratories, Inc., Approval